pembrolizumab
merck
['keynote-716', 'melanoma', 'pembro']
 present dmfs data for keynote-716 study of adj pembro for high-risk stage ii #melanoma. 976 pts randomized. a significant reduction in dmfs with a hr of 0.64 (p=0.0029) #asco22 
Associate professor in Surgery at Sahlgrenska University Hospital. @sahlgrenska @SahlgrenskaAcad @goteborgUni #wcmtm #melanoma #breastcancer #surgery